Acute Mesenteric Ischemia, Reality in Catalonia (AMI_CAT)
Reality of Acute Mesenteric Ischemia in Catalonia, is There a Chance to Improvement?
Study Overview
Status
Conditions
Detailed Description
Acute mesenteric ischaemia (AMI) is a notorious disease with a high mortality from 50 to 80%. Even though AMI is a relatively rare condition (1:1,000) the incidence rises exponentially with increasing age, in patients older than 75 years, the incidence of AMI has been reported higher than that of acute appendicitis. AMI patients benefit from early assessment in a surgical unit with capabilities to definitive management. The diagnosis and management of AMI are truly multidisciplinary, requiring high index of suspicion and awareness from emergency department physicians, preferably computed tomography angiography with precise interpretation, but usually this is not the truth reality and the diagnostic is delayed as well as the treatment, and the management is not multidisciplinary.
The aim of this study is to analyse the management and results of the patients admitted with an AMI in Catalonia from November 2024 to April 2026.
Study Type
Enrollment (Estimated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnostic of Acute Mesenteric Ischemia
Exclusion Criteria:
- Chronic Mesenteric Ischemia
- Ischemic Colitis
- Bowel obstruction strangulation
- Inflammatory bowel necrosis
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality
Time Frame: 2024-2026
|
To describe the mortality in patients with a diagnostic of AMI
|
2024-2026
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications
Time Frame: 2024-2026
|
To describe the complications in patients with a diagnostic of AMI
|
2024-2026
|
|
Management
Time Frame: 2024-2026
|
To describe the management in patients with a diagnostic of AMI
|
2024-2026
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AMICat Reality
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Mesenteric Ischemia
-
University of TartuNot yet recruitingAcute Mesenteric Ischemia
-
University of TartuCompletedAcute Mesenteric IschemiaSwitzerland, Estonia
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Aalborg University HospitalCompletedAcute Mesenteric Ischemia
-
Tartu University HospitalCompleted
-
University of TartuRecruitingAcute Mesenteric IschemiaEstonia
-
Hospital del MarNot yet recruitingAcute Mesenteric Ischemia
-
Assistance Publique - Hôpitaux de ParisRecruitingAcute Mesenteric IschemiaFrance
-
University Hospital RegensburgWilliam Cook EuropeUnknownAcute Mesenteric Ischemia | Bowel NecrosisGermany
-
University of GenovaUniversity of Bari; University of SienaUnknownAcute Mesenteric IschemiaItaly